Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Bigcountryhomepage

Published November 12, 2026

Trump administration will fund new research on controversial psychedelic drug ibogaine

Read the full story at Bigcountryhomepage

Releases · Ordinary Voices. Top Stories. Suspect accused of trafficking ... The Associated Press ' health and science coverage receives financial.

Surfaced by 11 Google Alerts

  • Psychedelic press release
  • Psychedelic crime
  • LSD
  • Magic mushrooms
  • Psychedelic biotech
  • Psychedelics
  • Ibogaine
  • Psychedelics europe
  • Psychedelics africa
  • Psychedelics south america
  • Psychedelics middle east